RAPT
Rapt Therapeutics Inc
Price:  
1.45 
USD
Volume:  
1,132,138.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RAPT WACC - Weighted Average Cost of Capital

The WACC of Rapt Therapeutics Inc (RAPT) is 8.6%.

The Cost of Equity of Rapt Therapeutics Inc (RAPT) is 13.55%.
The Cost of Debt of Rapt Therapeutics Inc (RAPT) is 5.00%.

Range Selected
Cost of equity 11.30% - 15.80% 13.55%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 7.5% - 9.7% 8.6%
WACC

RAPT WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.62 1.96
Additional risk adjustments 0.0% 0.5%
Cost of equity 11.30% 15.80%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 7.5% 9.7%
Selected WACC 8.6%